Determination of antibodies to Toxoplasma gondii and CMV in renal transplant recipients

By Iqbal J.   Nampoory M.R.N.   Johnv K.V.   Khalid N.   Al-Mousawi M.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2703-2705

Elsevier

Access to resources Recommend Favorite

Prophylaxis of cytomegalovirus disease with ganciclovir or anti-CMV immunoglobulin in renal transplant recipients who receive antilymphocytic antibodies as induction therapy

By Morales E.   Andres A.   Gonzalez E.   Herrero J.C.   Munoz M.A.   Ortiz M.   Espejo B.   Lumbreras C.   Morales J.M.   Aguado J.M.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 73-74

Elsevier

Access to resources Recommend Favorite

Efficacy of OKT3 as Primary Therapy for Histologically Confirmed Acute Renal Allograft Rejection in Simultaneous Kidney and Pancreas Transplant Recipients

By Peddi V.R.   Kamath S.   Schroeder T.J.   Munda R.   First M.R.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 285-287

Elsevier

Access to resources Recommend Favorite

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis

By Anglicheau D.   Lautrette A.   Scieux C.   Thervet E.   Martinez F.   Flamant M.   Morinet F.   Legendre C.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2826-2827

Elsevier

Access to resources Recommend Favorite

Clinical pattern, risk factors, and outcome of CMV infection in renal transplant recipients: local experience

By Yeung J.S.   Tong K.L.   Chan H.W.H.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3144-3145

Elsevier

Access to resources Recommend Favorite